Financial Performance - Net profit attributable to shareholders for Q1 2025 was CNY 2,248,217.51, down 48.89% year-over-year[9] - Operating revenue for Q1 2025 was CNY 17,022,544.84, representing an 8.16% decline compared to the same period last year[9] - The company experienced a 44.85% decline in operating profit, amounting to CNY 3,207,593.77, influenced by rising raw material costs and weak market demand[12] - Total operating revenue for Q1 2025 was ¥17,022,544.84, a decrease from ¥18,534,621.71 in Q1 2024, representing a decline of approximately 8.14%[36] - Net profit for Q1 2025 was ¥2,248,217.51, down from ¥4,398,778.98 in Q1 2024, indicating a decrease of approximately 48.91%[37] - Basic earnings per share decreased to CNY 0.03 from CNY 0.05 year-over-year[39] Assets and Liabilities - Total assets as of March 31, 2025, were CNY 358,898,039.96, a decrease of 0.80% compared to the end of the previous year[9] - The company reported a total asset value of ¥358,898,039.96, down from ¥361,778,172.84[30] - Total liabilities decreased to ¥26,562,094.93 from ¥31,690,445.32, a reduction of about 16.3%[31] - Total liabilities decreased to ¥26,562,094.93 in Q1 2025 from ¥31,690,445.32 in the previous year, a reduction of approximately 16.4%[35] - Shareholders' equity increased to ¥332,335,945.03 from ¥330,087,727.52, showing a growth of approximately 0.7%[31] - Owner's equity increased slightly to ¥332,336,360.42 in Q1 2025 from ¥330,087,814.12 in Q1 2024, showing a growth of about 0.68%[35] Cash Flow - The company's cash flow from operating activities showed a net outflow of CNY 7,876,472.18, worsening by 6.82% compared to the previous year[9] - Cash inflow from operating activities was CNY 15,242,896.92, up from CNY 13,372,342.09 in the same period last year, representing an increase of approximately 13.94%[40] - Cash outflow from operating activities totaled CNY 23,119,369.10, compared to CNY 20,745,817.05 in the previous year, reflecting an increase of about 11.46%[41] - Net cash flow from operating activities was negative at CNY -7,876,472.18, worsening from CNY -7,373,474.96 year-over-year[41] - Cash inflow from investment activities was CNY 30,148,651.47, primarily from cash recovered from investments[41] - Cash outflow from investment activities was CNY 3,591,820.32, down from CNY 32,977,896.90 in the previous year, indicating a significant reduction[41] - Net cash flow from financing activities was CNY 24,476,035.95, primarily due to cash received from borrowings of CNY 25,095,145.39[41] - The ending cash and cash equivalents balance decreased to CNY 56,066,652.21 from CNY 59,918,776.84 year-over-year[41] - The company reported a net increase in cash and cash equivalents of CNY -11,468,292.50 for the current period[41] Expenses - Research and development expenses increased by 38.60% year-over-year, totaling CNY 1,293,708.77, to enhance product competitiveness and develop new products[11] - Management expenses rose by 74.29% year-over-year, totaling CNY 2,562,638.39, primarily due to increased depreciation and consulting fees[12] - Total operating costs increased to ¥17,089,678.17 in Q1 2025 from ¥16,129,330.44 in Q1 2024, marking an increase of about 5.95%[36] - Financial expenses showed a net income of -¥276,541.00 in Q1 2025, compared to -¥126,349.27 in Q1 2024, indicating a worsening of financial costs[36] - Investment income recorded a loss of ¥241,932.12 in Q1 2025, contrasting with a gain of ¥62,984.01 in Q1 2024[36] Shareholder Information - Major shareholders include Wei Wenxu with 22.32% and Ma Junqiang with 16.76% of shares[18] - The total number of shares held by the top ten shareholders is 55,661,650, representing 64.72% of total shares[19] - There are no pledged or judicially frozen shares among the top ten shareholders[20] Legal and Compliance - The company is involved in litigation with a total claim amount of 1,110,862.09, which accounts for 0.33% of the net assets[23] - The company has pledged receivables worth 7,685,684.59, representing 2.14% of total assets[24] - The total value of assets with restricted rights is 8,641,816.90, accounting for 5.86% of total assets[24] - The company has no adverse effects from the pledged assets as they are part of normal business operations[25] - The financial report has not been audited[27] - The consolidated balance sheet is presented in yuan[28]
科创新材(833580) - 2025 Q1 - 季度财报